HOTH
Hoth Therapeutics Inc
NASDAQ · Pharmaceuticals
$0.81
+0.04 (+4.95%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.55M | 4.47M | 5.09M |
| Net Income | 883.9K | 919.3K | 807.7K |
| EPS | — | — | — |
| Profit Margin | 19.4% | 20.6% | 15.9% |
| Rev Growth | +13.3% | +17.8% | +20.0% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 3.76M | 4.02M | 3.76M |
| Total Equity | 5.62M | 6.75M | 6.78M |
| D/E Ratio | 0.67 | 0.60 | 0.55 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 1.12M | 1.15M | 1.14M |
| Free Cash Flow | 1.08M | 1.03M | 790.7K |